Todos Medical Enters Into Cross-Distribution Agreement With

New Post Public Reply Private Reply Replies (0) Message Board
Mauibound
498
Todos Medical Enters Into Cross-Distribution Agreement With L1 Systems for Ventilators and COVID Testing

MAY 26, 2020 9:19AM EDT


 Todos gains distribution rights to LifeCan Ventilator in Brazil, Mexico & Latin America  

Ventilator access will help prospective government and NGO procurers of COVID-related medical products reduce need for additional suppliers to address critical health needs 

L1 distribution network will provide untapped market access for Todos’ tests

REHOVOT, Israel, SINGAPORE and NEW YORK, NY, May 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on the distribution of a comprehensive suite of solutions for the screening and diagnosis of COVID-19 and the development of blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into a cross-distribution agreement with L1 Systems, Ltd., a wholly-owned subsidiary of Medigus, Ltd. (NASDAQ:MDGS) (TASE:MDGS), for the distribution of COVID-19 related products, including ventilators. Todos is making available to L1 its comprehensive suite of testing solutions that covers best-in-class RNA extraction equipment, RNA extraction reagents, qPCR reagents, Digital PCR reagents and US-validated SARS-CoV-2 rapid point-of-care antibody test kits for non-exclusive distribution. L1 is making available to Todos the LifeCan ventilators, manufactured by Elbit Systems, for non-exclusive distribution in Mexico and Latin America, including Brazil. This agreement strengthens both companies’ core offerings and allows each company to focus on markets where they are developing reliable sales channels. 

“Given that Todos’ team has been focused recently on penetrating the Latin American market, where a marked uptick in COVID-19 infections has led to a significantly increased need for COVID-19 testing and critical care treatment options, we believe gaining access to a high quality medical grade ventilator will further bring attention to Todos’ test offering due to the severe global shortage in ventilators,” said Gerald Commissiong, President & CEO of Todos Medical. 

Mr. Commissiong continued, “When a country is dealing with a pandemic crisis such as COVID-19, getting trusted sources of medical supplies from which a procurement agent can acquire multiple lines of needed products substantially increases a supplier’s profile within that procurement agency, and provides the supplier an opportunity to expose the procurer to the rest of its portfolio in a more comprehensive way. Ventilators are often the difference between life and death when treating patients, and we believe getting access to a nimble and tailored product such as LifeCan – a simple, high-quality product that was designed in Israel to respond to many of the recent concerns with the established medical ventilator designs – gives Todos a significant edge when competing for contracts from foreign governments, hospital systems and others users of healthcare products and services. As we continue to build our international import/export division, this agreement positions Todos to stand out from other companies competing for contracts in key markets.”

About the SARS-CoV-2 Coronavirus (COVID-19)

Coronaviruses are a family of viruses that can lead to respiratory illness, including Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses can be transmitted between animals and people and evolve into strains not previously identified in humans. On January 7, 2020, a novel coronavirus (SARS-CoV-2) was identified as the cause of pneumonia cases in Wuhan, Hubei Province of China, and additional cases have been found in a growing number of countries worldwide. COVID-19 is the disease caused by SARS-CoV-2.

About Medigus, Ltd.

Medigus is traded on the Nasdaq Capital Market and the TASE (Tel Aviv Stock Exchange). To learn more about the company’s advanced technology, please visit www.medigus.com.

About Todos Medical Ltd.

Headquartered in Rehovot, Israel, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe and are currently in a pre-commercial study with its distribution partner Orot+ (a division of Luces-Orot). Todos recently entered into an exclusive option agreement to acquire U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab and Provista's proprietary commercial-stage Videssa® breast cancer blood test. The transaction is expected to close in the second quarter of 2020.

Through Breakthrough Diagnostics, Inc., its joint venture with Amarantus Bioscience Holdings, Inc. (OTC: AMBS), Todos is also actively involved with the development of blood tests for the early detection of neurodegenerative disorders, such as Alzheimer's disease. Todos expected to complete the remaining unowned interest in Breakthrough in the second quarter of 2020.

Todos recently entered into distribution agreements with companies to distribute certain novel coronavirus (COVID-19) test kits. The Company has entered into distribution agreements with multiple international suppliers of PCR testing kits and related materials and supplies, as well as antibody testing kits from multiple manufacturers after completing validation of said testing kits and supplies in its partner CLIA/CAP certified laboratory in the United States. Todos has formed Corona Diagnostics, LLC, a strategic collaboration with Emerald Organic Products, Inc.  (OTC: EMOR), to support telemedicine and virtual pharmacy aspects of the commercialization of its COVID-19 return to work testing programs in the US.

For more information, please visit https://www.todosmedical.com/  

https://investor.todosmedical.com/news-events...ement-with

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 22

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 48

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 23

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
COP31 Puts China’s Weather-to-Energy Model on View

Updated Category News Views 68

Storm maps are becoming operating manuals, and that is the hard reality behind a November 13 COP31 event in Antalya, Türkiye. The session, “From Early Warning to Energy Action: Pathways for Global Climate Diplomacy and Cooperation,” put China’s effort to tie meteorological intelligence to energy-system decisions under an international spotlight. This is not...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 15

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
RLX Revenue Soars, but European Margins Need Proof

Updated Category News Views 104

Revenue can wear a fancy suit while earnings arrive in work boots, and RLX Technology's third quarter is exactly that kind of report. The newly consolidated European distribution business pushed third-quarter revenue to RMB1.92 billion, up 69.7% year over year. That is a real jump, not pocket change. But the same acquisition also changed the mix, squeezed the blended...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 21

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Global-E Faces Fresh Scrutiny After Muted Quarterly Outlook

Updated Category News Views 39

A guidance bump that barely clears the curb can still wreck a stock. That is the unpleasant read-through from Global-E Online's third-quarter 2026 report: revenue guidance went higher, but not high enough to persuade investors that the business was pulling away from expectations. Shares fell after the release, and a securities-law investigation announced November 19 has...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading

Top 5 Most Recently Viewed Articles

Keurig Dr Pepper Acquires JDE Peet's for Coffee Market Leadership

Updated Category News Views 145

Keurig Dr Pepper's Strategic Acquisition of JDE Peet's This acquisition represents a significant moment for Keurig Dr Pepper (NASDAQ: KDP) as it moves to establish itself as a dominant force in the global coffee market. By acquiring JDE Peet's, KDP aims to leverage its extensive portfolio and innovative capabilities to serve coffee lovers in over 100 countries. The two...

Continue Reading
Jetcraft Strengthens EMEA Sales Team with New Director Role

Updated Category News Views 42

Jetcraft Enhances Its EMEA Sales Strategy with New Director Jetcraft has recently made a significant addition to its EMEA sales team by appointing Anna Gulbas as the new Sales Director. This move marks the completion of their newly structured sales team in Europe, positioning the company to strengthen its presence in the business aviation sector. Anna Gulbas’s Extensive...

Continue Reading
i-Function® Teams with Lunavi for Innovative Cognitive Screening

Updated Category News Views 259

Innovative Partnership for Cognitive Health i-Function®, a forward-thinking company specializing in cognitive wellness and independent living, has joined forces with Lunavi, a premier digital solutions provider. Together, they have successfully introduced the LASSI-D™ platform, an innovative tool designed to facilitate early detection of Mild Cognitive Impairment...

Continue Reading
Uncovering Concerns: Health Risks of Depo-Provera and Pfizer

Updated Category News Views 394

Investigating Potential Issues within Pfizer Inc. Recently, a significant investigation has emerged focusing on Pfizer Inc. (NYSE: PFE) and its Board of Directors. This inquiry is centered around concerns regarding possible breaches of fiduciary duties related to the company's handling of Depo-Provera, a contraceptive injectable. Many are seeking clarity on how these...

Continue Reading
Celebrating Workplace Excellence at GetMed Staffing Again

Updated Category News Views 175

GetMed Staffing Achieves Top Honor in Employee Satisfaction GetMed Staffing is proud to announce its accomplishment as the #1 Best Place to Work in Omaha for the third consecutive year. This prestigious recognition, supported by the Greater Omaha Chamber and facilitated by Baird Holm LLP, showcases GetMed Staffing's unwavering commitment to building a workplace that...

Continue Reading